Comparative analysis of histological and immunohistological features in mycosis fungoides and Sezary syndrome

Journal of Cutaneous Pathology

Volumn 25, Issue 8, 1998, Pages 407-412

  Kamarashev, J ^a   Burg, G ^a   Kempf, W ^a   Hess Schmid, M ^a   Dummer, R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD15 ANTIGEN; CD28 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; FAS LIGAND; GLYCOPROTEIN GP 39; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ACANTHOSIS; ADULT; AGED; ARTICLE; CELL GROWTH; CLINICAL ARTICLE; COMPARATIVE STUDY; EPIDERMIS CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; MALE; MYCOSIS FUNGOIDES; PATHOGENESIS; PLAQUE FORMING CELL; RETROSPECTIVE STUDY; SEZARY SYNDROME; SKIN CELL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD15; ANTIGENS, CD28; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; ANTIGENS, NEOPLASM; CD40 LIGAND; FAS LIGAND PROTEIN; FEMALE; HUMANS; IMMUNOCONJUGATES; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MYCOSIS FUNGOIDES; SEZARY SYNDROME; SKIN; SKIN NEOPLASMS;

EID: 0031687733     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1998.tb01766.x     Document Type: Article

References (22)

1. Burg G, Dummer R, Kerl H. Classification of cutaneous lymphomas, Dermatol Clin 1994: 12: 213.
2. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997: 90: 354.
3. Alibert JLM. Description des Maladies de la Peau, Observée a l'Hopital Saint Louis. Paris: Barriois L'Aine & Fils, 1806.
4. Besnier E, Hallopeau H. On the erythroderma of mycosis fungoides. J Cutan Genito Urin Dis 1892: 10: 453.
5. Sézary A, Bouvrain Y. Erythrodermie avec presence cellules monstrueuses dans le derme et dans le sang circulant. Bull Soc Fr Dermatol Syphil 1938: 45: 254.
6. Willemze R, van Vloten WA, Hermans J, Damsteeg MJ, Meijer CJ. Diagnostic criteria in Sezary's syndrome: a multiparameter study of peripheral blood lymphocytes in 32 patients with erythroderma. J Invest Dermatol 1983: 81: 392.
7. Sentis HJ, Willemze R, Scheffer E. Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: A comparison with benign forms of erythroderma. J Am Acad Dermatol 1986: 15: 1217.
8. Geib A, Smoller B, Warnke R, Picker L. Lymphocytes infiltrating primary cutaneous neoplasms selectively express the cutaneous lymphocyte-associated antigen (CLA). Am J Pathol 1993: 142: 1556.
9. Dummer R, Schwarz T. Cytokines as regulatory proteins in cutaneous lymphoproliferation, Dermatol Clin 1994: 12: 283.
10. Wood GS. Benign and malignant cutaneous lymphoproliferative disorders including Mycosis fungoides. In: Knowles DM, ed., Neoplastic haematology, pp. 917-52. Baltimore: Williams & Wilkins, 1992.
11. Imai S, Burg G, Braun-Falco O. Mycosis fungoides and Sezary's syndrome show distinct histomorphological features. Dermatologica 1986: 173: 131.
12. Kohler S, Kim YH, Smoller BR. Histologic criteria for the diagnosis of erythrodermic mycosis fungoides and Sezary syndrome: a critical reappraisal. J Cutan Pathol 1997: 24: 292.
13. Trotter MJ, Whittaker SJ, Orchard GE, Smith NP. Cutaneous histopathology of Sezary syndrome: a study of 41 cases with a proven circulating T-cell clone, J Cutan Pathol 1997: 24: 286.
14. Nickoloff BJ, Griffiths CE, Baadsgaard O, Voorhees JJ, Hanson CA, Cooper KD. Markedly diminished epidermal keratinocyte expression of intercellular adhesion molecule-1 (ICAM1) in Sezary syndrome. J Am Med Assoc 1989: 261: 2217.
15. Heald PW, Yan SL, Edelson RL, Tigelaar R, Picker LJ. Skin-selective lymphocyte homing mechanisms in the pathogenesis of leukemic cutaneous T-cell lymphoma. J Invest Dermatol 1993: 101: 222.
16. Oishi M, Maeda K, Sugiyama S. Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocytes and squamous cell carcinoma. Arch Dermatol Res 1994: 286: 396.
17. Owen-Schaub LB, Meterissian S, Ford RJ. Fas/APO-1 expression and function on malignant cells of hematologic and nonhematologic origin. J Immunother 1993: 14: 234.
18. Robertson MJ, Manley TJ, Pichert G, et al. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. Leuk Lymphoma 1995: 17: 51.
19. Stuber E, Strober W, Neuraht M. Blocking the CD40-ligand-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 1996: 183: 693.
20. Dummer R, Heald PW, Nestle FO, et al. Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). Blood 1996: 88: 1383.
21. Borrow P, Tishon A, Lee S, et al. CD40-ligand-deficient mice show deficits in antiviral immunity and have an impaired memory CDS+ CTK response. J Exp Med 1996: 183: 2129.
22. Xerri L, Devilard E, Hassoun J, Olive D, Birg F. In vivo expression of the CTLA-4 inhibitory receptor in malignant and reactive cells from human lymphomas. J Pathol 1997: 183: 182.